Clinical Trial Update: A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of IMM2510 and IMM27M in patients with hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• IMM2510
• IMM27M

Snippet

Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | Conditions: Advanced Solid Tumors, HCC | Phase 1 | Status: RECRUITING